Jan 10, 2017 12:01 pm UTC| Business
HAIFA, Israel, Jan. 10, 2017 -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy products, today announced that the Company’s Phase III study of its PLX-PAD cells...
SES Selects Monics® Enterprise From Kratos to Expand Satellite Fleet RF Monitoring Capabilities
Jan 10, 2017 12:01 pm UTC| Business
SAN DIEGO, Jan. 10, 2017 -- Kratos Defense Security Solutions, Inc. (Nasdaq:KTOS), a leading National Security Solutions provider, announced today that SES, the world-leading satellite operator, has selected Kratos’...
SES Selects Monics® Enterprise From Kratos to Expand Satellite Fleet RF Monitoring Capabilities
Jan 10, 2017 12:01 pm UTC| Business
SAN DIEGO, Jan. 10, 2017 -- Kratos Defense Security Solutions, Inc. (Nasdaq:KTOS), a leading National Security Solutions provider, announced today that SES, the world-leading satellite operator, has selected Kratos’...
Jan 10, 2017 12:01 pm UTC| Business
SALT LAKE CITY, Jan. 10, 2017 -- Sera Prognostics, Inc., a woman’s healthcare company, announced today that it has entered into a strategic collaboration with Laboratory Corporation of America® Holdings (LabCorp®)...
Jan 10, 2017 12:01 pm UTC| Business
SALT LAKE CITY, Jan. 10, 2017 -- Sera Prognostics, Inc., a woman’s healthcare company, announced today that it has entered into a strategic collaboration with Laboratory Corporation of America® Holdings (LabCorp®)...
ESI Strengthens Cash Position and Announces Preliminary Third Quarter Orders
Jan 10, 2017 12:00 pm UTC| Business
PORTLAND, Ore., Jan. 10, 2017 -- Electro Scientific Industries, Inc. (Nasdaq:ESIO), an innovator in laser-based manufacturing solutions for the micro-machining industry, announced that CEO Michael Burger will be...
Actinium Pharmaceuticals to Present at 9th Annual Biotech Showcase™ 2017 Conference
Jan 10, 2017 12:00 pm UTC| Business
NEW YORK, Jan. 10, 2017 -- Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) ("Actinium" or "the Company"), a biopharmaceutical company developing innovative targeted therapies for cancers lacking effective treatment...